Prime Healthcare Group acquires advanced cancer treatment technology from Varian and extends its long-term partnership with Siemens Healthineers in the region

Prime Healthcare Group announced a strategic collaboration with Varian, a Siemens Healthineers company, and the acquisition of a Truebeam® radiotherapy system and Bravos® afterloader system for the upcoming Marie Curie Cancer Institute (MCCI). The cancer center will provide a comprehensive cancer care system including medical oncology, surgical oncology and radiation oncology. 

Announcing the strategic collaboration at Arab Health, 2023, Dr. Jamil Ahmed, Managing Director of the Group said, "We are going to work with Varian, a Siemens Healthineers company, and extended the long-term collaboration with Siemens Healthineers in the region. Prime Health Care has acquired a TrueBeam® radiotherapy system and BRAVOS® afterloader system."

Laurent Amiel, President Radiation Oncology Solutions EMEA at Varian, a Siemens Healthineers company, further elaborated, “As the cancer burden continues to rise, we are proud to work with Prime Hospital to expand access to high quality cancer care. Together with Siemens Healthineers, we support the entire cancer care pathway, from screening to survivorship, giving us an important opportunity to improve the care experience for patients and clinicians alike. We look forward to extending our reach and advancing our mission to create a world without fear of cancer.”

The foundation for this extended partnership is the existing and trusting long-term relationship between Prime Healthcare Group and Siemens Healthineers, which entails the equipment and servicing of the radiology department of Prime Healthcare Group facilities in Dubai.

Ole Per Maloy, Zone Head MESA, SHS EMEA MESA highlighted that “We as Siemens Healthineers, with our colleagues from Varian, are delighted to partner with Prime Hospital as we are joining forces to address the complete cancer care continuum, ultimately helping to pave the way for intelligent cancer care. This collaboration can be a prototype for the region of how we can accelerate patient impact and transform oncology through synergies from our comprehensive and complementary portfolio based on integrated, connected care pathways, from best-in-class imaging to cancer therapy and follow-up care.”

The Marie Curie Cancer Institute (MCCI) will be an integral part of Prime Healthcare Group’s 450-million Dirham multi-specialty hospital, coming up in Dubai’s Healthcare City district. The groundbreaking ceremony for the new hospital took place earlier in December 2022.